Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can amino acid shakes help liver patients regain muscle?

NCT ID NCT06121479

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 37 times

Summary

This study tests whether taking branched-chain amino acid (BCAA) supplements twice daily for 12 weeks can improve muscle thickness and nutrition in people with decompensated cirrhosis and ascites (fluid in the belly). Thirty adults with low albumin levels will receive the supplement and undergo measurements of muscle, strength, and blood markers. The goal is to see if BCAA can counteract muscle wasting common in advanced liver disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DECOMPENSATED CIRRHOSIS AND ASCITES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Bangkok, Bangkok, 10700, Thailand

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

branched-chain amino acids (BCAA)

What this could lead to

If successful, this could show that BCAA supplements help improve muscle mass and nutrition in people with advanced liver disease and fluid buildup.

What could go wrong

This is a small pilot study with only 30 participants, so results may not apply to everyone. It focuses on short-term nutritional changes, not long-term survival or liver function.

Conditions

The condition(s) this trial relates to.

Ascites chronic liver failure cirrhosis of liver

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.